竞争风险模型预测19-24周小於胎龄儿
本研究基于96678例单胎妊娠的前瞻性观察数据,开发并内部验证了一个竞争风险模型,联合母体人口学特征、病史与19-24周超声估计胎儿体重、子宫动脉搏动指数及平均动脉压,预测小於胎龄儿。模型在10%假阳性率下对<10百分位、<37周分娩的检出率为56%,对<3百分位、<32周分娩的检出率达77%,且校准良好。
要点
- 竞争风险模型联合母体因素与生物物理标志物可个体化预测SGA风险。
- 10%假阳性率下,<10百分位且<37周分娩的SGA检出率为56%。
- 合并子痫前期时,<10百分位且<32周分娩的SGA检出率可达91%。
核心结论
- 联合母体因素与估计胎儿体重、子宫动脉搏动指数及平均动脉压的竞争风险模型,对SGA的筛查性能优于仅用母体特征和病史。
研究设计与样本
- 前瞻性观察研究纳入96678例19-24周常规超声检查的单胎妊娠孕妇,记录估计胎儿体重、子宫动脉搏动指数和平均动脉压,随机分为训练集和测试集进行内部验证。
主要发现
- 估计胎儿体重采用含分娩孕周与出生体重z评分交互项的回归模型描述,子宫动脉搏动指数和平均动脉压采用折叠平面回归模型拟合。
- 10%假阳性率下,联合筛查对<10百分位SGA且分娩孕周≥37、<37、<32周的检出率分别为41%、56%、70%。
- 对<3百分位SGA且分娩孕周≥37、<37、<32周的检出率分别为47%、65%、77%。
- 合并子痫前期时,<10百分位SGA且分娩孕周≥37、<37、<32周的检出率分别为41%、72%、91%;<3百分位分别为50%、75%、92%。
- 模型整体校准良好,训练集与测试集的检出率和校准指数相似,显示内部有效性。
临床怎么用
- 可在19-24周超声检查时整合母体因素、估计胎儿体重、子宫动脉搏动指数和平均动脉压,使用竞争风险模型个体化评估SGA风险。
- 该模型可提供任意出生体重z评分和分娩孕周切点的患者特异性风险,便于分层管理。
局限性
- 原文未报告外部验证结果,仅进行了内部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antenatal identification of women at high risk to deliver small-for-gestational-age neonates may improve the management of the condition. The traditional but ineffective methods for small-for-gestational-age screening are the use of risk scoring systems based on maternal demographic characteristics and medical history and the measurement of the symphysial-fundal height. Another approach is to use logistic regression models that have higher performance and provide patient-specific risks for different prespecified cutoffs of birthweight percentile and gestational age at delivery. However, such models have led to an arbitrary dichotomization of the condition; different models for different small-for-gestational-age definitions are required and adding new biomarkers or examining other cutoffs requires refitting of the whole model. An alternative approach for the prediction of small-for-gestational-age neonates is to consider small for gestational age as a spectrum disorder whose severity is continuously reflected in both the gestational age at delivery and z score in birthweight for gestational age. OBJECTIVE: This study aimed to develop a new competing risks model for the prediction of small-for-gestational-age neonates based on a combination of maternal demographic characteristics and medical history with sonographic estimated fetal weight, uterine artery pulsatility index, and mean arterial pressure at 19 to 24 weeks' gestation. STUDY DESIGN: This was a prospective observational study of 96,678 women with singleton pregnancies undergoing routine ultrasound examination at 19 to 24 weeks' gestation, which included recording of estimated fetal weight, uterine artery pulsatility index, and mean arterial pressure. The competing risks model for small for gestational age is based on a previous joint distribution of gestational age at delivery and birthweight z score, according to maternal demographic characteristics and medical history. The likelihoods of the estimated fetal weight, uterine artery pulsatility index, and mean arterial pressure were fitted conditionally to both gestational age at delivery and birthweight z score and modified the previous distribution, according to the Bayes theorem, to obtain an individualized posterior distribution for gestational age at delivery and birthweight z score and therefore patient-specific risks for any desired cutoffs for birthweight z score and gestational age at delivery. The model was internally validated by randomly dividing the data into a training data set, to obtain the parameters of the model, and a test data set, to evaluate the model. The discrimination and calibration of the model were also examined. RESULTS: The estimated fetal weight was described using a regression model with an interaction term between gestational age at delivery and birthweight z score. Folded plane regression models were fitted for uterine artery pulsatility index and mean arterial pressure. The prediction of small for gestational age by maternal factors was improved by adding biomarkers for increasing degree of prematurity, higher severity of smallness, and coexistence of preeclampsia. Screening by maternal factors with estimated fetal weight, uterine artery pulsatility index, and mean arterial pressure, predicted 41%, 56%, and 70% of small-for-gestational-age neonates with birthweights of <10th percentile delivered at ≥37, <37, and <32 weeks' gestation, at a 10% false-positive rate. The respective rates for a birthweight of <3rd percentile were 47%, 65%, and 77%. The rates in the presence of preeclampsia were 41%, 72%, and 91% for small-for-gestational-age neonates with birthweights of <10th percentile and 50%, 75%, and 92% for small-for-gestational-age neonates with birthweights of <3rd percentile. Overall, the model was well calibrated. The detection rates and calibration indices were similar in the training and test data sets, demonstrating the internal validity of the model. CONCLUSION: The performance of screening for small-for-gestational-age neonates by a competing risks model that combines maternal factors with estimated fetal weight, uterine artery pulsatility index, and mean arterial pressure was superior to that of screening by maternal characteristics and medical history alone.
引用
- Papastefanou I, Nowacka U, Syngelaki A, et al. Competing risks model for prediction of small-for-gestational-age neonates from biophysical markers at 19 to 24 weeks' gestation. Am J Obstet Gynecol. 2021. PMID: 33901487. doi:10.1016/j.ajog.2021.04.247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。